• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Alliance Fellows

2026 Alliance Fellows

The Alliance Fellows Program (formerly Global Research Ambassadors) is a virtual learning and engagement program for people impacted by ALS/MND worldwide who want to deepen their understanding of ALS/MND research, treatment development, and advocacy.

Through self-directed online learning and interactive live sessions, participants build the knowledge, skills, and confidence to engage more meaningfully in research and advocacy conversations within the global ALS/MND community.

2026 Applications Are Now Closed

Thank you to everyone who applied for the 2026 Alliance Fellows Program.

2026 Program Details

Delivery
Fully virtual, using Zoom and an online learning platform
Duration
Four-week program delivered between September 21 and October 23 (dates tentative)
Pre-session learning
Approximately 1.5 hours of individual online learning and preparation before each live session
Live sessions
Nine 90-minute interactive sessions delivered across the program

The program uses a blended learning approach combining self-paced learning with live interactive sessions. Participants engage with expert faculty and peers through discussions, practical exercises, case studies, and collaborative activities.

Live session times will vary to support participation across time zones. Sessions may be scheduled at different times throughout the day, and recordings will be available for participants who are unable to attend live.

Who Can Apply

The Alliance Fellows Program is designed for people with a personal connection to ALS/MND and an interest in research, advocacy, and learning.

You are encouraged to apply if you are:

  • Living with ALS/MND
  • A current or former caregiver
  • An ALS/MND gene carrier without a diagnosis
  • A family member
  • Another member of the ALS/MND community with a strong interest in research and advocacy

Each applicant must submit a separate application.

What You’ll Learn and Gain

The program builds understanding of ALS/MND research and treatment development, clinical trials, scientific communication, research ethics, informed consent, and the important role lived experience plays in shaping research and advocacy.

Participants leave the program with:

  • A stronger understanding of ALS/MND research and treatment development
  • Greater confidence discussing scientific developments
  • Practical tools for advocacy and community engagement
  • Connections with researchers, clinicians, and peers from around the world
  • Recognition as an Alliance Fellow

After Completing the Program

Participants who complete the program receive a certificate of completion, an Alliance Fellow social media badge, recognition through Alliance communications, and opportunities to continue engaging through the Global ALS/MND Experience Network (GAMEN).

A Global Learning Community

One of the program’s greatest strengths is the global community it creates, connecting people affected by ALS/MND across countries, experiences, and perspectives. Bringing lived experience into research conversations can strengthen advocacy, deepen understanding of community priorities, and contribute to more meaningful research.

What Participation Involves

Participants should be interested in learning about ALS/MND research and treatment development, willing to actively participate in discussions and learning activities, and interested in connecting with others across the global ALS/MND community.

To participate, you will need a device with internet access and a webcam, time to attend most live sessions or watch recordings, and a willingness to learn and contribute to discussions.

If selected, participants are expected to review materials in advance, participate actively in sessions, and share what they learn with their communities following the program.

Introducing the 2026 Alliance Fellows

Meet the 28 Fellows from around the world taking part in the 2026 Alliance Fellows Program.

Gurpreet Bansal
United Kingdom
Maryna Borodina
Ukraine
Michael Broadhacker
USA
Josie Caruso
Australia
E. Alexander Cooper
Canada
Olivia D’Amici
Canada
Robert Ferrari
Australia
Louise Gunning
Netherlands
Aaron Hinttala
Australia
Gisli Jonasson
Iceland
Alper Kaya
Türkiye
Hayley King
Canada
Zeynep Kusku Kiraz
Türkiye
Philip Langat
Kenya
Louise Nkusu Lusangu
South Africa
Assunta Meleca
Australia
Cynthia Mendes
Brazil
Harlina Binti Mohd
Malaysia
(Zahid) Ahmad Nurzahid Mohd Yusoff
Malaysia
Mary Mwandawiro
Kenya
Sylvia Nzambu
Kenya
Jette Odgaard Villemoes
Denmark
Paola Prada
Colombia
Hemangi Sane
India
Kenneth Sanderson
Canada
Michelle Schmitz
USA
Giulia Valente
Australia
Phil Ward
United Kingdom

Primary Sidebar

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Anita Forte, USA

    Anita Forte, USA

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Susan Keldani, USA

    Susan Keldani, USA

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Anna Barrow, UK

    Anna Barrow, UK

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Bob Simonds, USA

    Bob Simonds, USA

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • David Hall, USA

    David Hall, USA

  • Christian Bär, Germany

    Christian Bär, Germany

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Elkin Ramiro Gaviria Muñoz, Colombia

    Elkin Ramiro Gaviria Muñoz, Colombia

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Bayley, Australia

    Bayley, Australia

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Liam Dwyer, England

    Liam Dwyer, England

  • Mike Cels, Canada

    Mike Cels, Canada

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Ann Nicol, USA

    Ann Nicol, USA

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Luis Antonio Pimenta Lima, Brazil

    Luis Antonio Pimenta Lima, Brazil

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login